Chikungunya in a pediatric cohort: Asymptomatic infection, seroconversion, and chronicity rates
PLOS Neglected Tropical Diseases · 16.07.2025 · 19 (7) · e0013254
DOI: 10.1371/journal.pntd.0013254 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 16.07.2025. Verfasst von Blenda de Jesus Pereira und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Medicina e Saúde Pública de Precisão, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil. Hauptthemen laut MEDLINE: Chikungunya Fever, Seroconversion, Chikungunya virus, Asymptomatic Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordination for the Improvement of Higher Education Personnel – Brazil (CAPES), Bahia State Research Support Foundation (FAPESB), Program for Supporting Centers of Excellence – Pronex.
Abstract (Originalsprache)
Chikungunya disease, caused by the chikungunya virus (CHIKV), is an acute febrile syndrome that frequently leads to chronic musculoskeletal manifestations. Little is known about the incidence, asymptomatic rate, seroconversion and chronicity after acute CHIKV infection in children and adolescents. We leveraged a nested cohort study within a phase III clinical trial of the Dengue vaccine by the Butantan Institute (DEN-03-IB), in Simões Filho (Bahia-Brazil) to characterize the dynamics of CHIKV infection in the pediatric population. 348 volunteers were included between 2018–2020 and followed for up to three years. Arbovirus surveillance was conducted during medical visits using 1) routine study visits with periodic blood collection; 2) visits due to adverse events (any symptom or illness); and 3) visits due to febrile episodes, with routine blood samples tested for chikungunya, Dengue, and Zika by viral RNA detection using RT-PCR. For cases with suspected arbovirus infection, symptoms and signs were collected with a structured questionnaire. At baseline, 7% (23/348) were positive for antichikungunya IgG. Among 311 that completed follow up (41 months, IQR 38–43), 17% tested positive for CHIKV, with 25 cases positive by RT-PCR and 28 cases by serology. 9.4% were asymptomatic and 3 (12%) developed chronic arthralgia. By the end of the study, only onefifth have been exposed to CHIKV despite several local outbreaks. Seroconversion rate among RT-PCR positive cases was 84%. Chronic arthralgia, though infrequent, was observed in the pediatric population. Our study demonstrates that, within the pediatric population, most CHIKV infections are symptomatic. We observed a small but significant frequency of negative antibody responses following acute infection and instances of chronic disease. These findings underscore the necessity for continuous surveillance and tailored interventions to tackle the unique challenges chikungunya presents in children and adolescents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratório de Medicina e Saúde Pública de Precisão, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil.
- Universidade Federal da Bahia, Salvador, Bahia, Brazil.
- Faculdade ZARNS, Salvador, Bahia, Brazil.
- Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
- Instituto Butantan, São Paulo, São Paulo, Brazil.
- Instituto de Investigação em Imunologia, São Paulo, Brazil.
ORCID-Profile: Blenda de Jesus Pereira, Viviane Sampaio Boaventura
Förderung
- Coordination for the Improvement of Higher Education Personnel – Brazil (CAPES)
- Bahia State Research Support Foundation (FAPESB)
- Program for Supporting Centers of Excellence – Pronex
- Graduate Program in Health Sciences (PPGCS)
- Royal Society
- Brazilian National Council for Scientific and Technological Development (CNPq)
- CAPES
- Bahia State Research Support Foundation (FAPESB), Program for Supporting Centers of Excellence – Pronex
Zitieren
APA
de Jesus Pereira, B., Brasil, M. Q. A., Silva, J. J., Cristal, J. R., Carvalho, I. P., Miranda, M. C. P., Paixão, D., Khouri, R., Cerqueira-Silva, T., Boulos, F. C., Barral-Netto, M., Kalas, E. G., Barral, A., Bandeira, A., & Boaventura, V. S. (2025). Chikungunya in a pediatric cohort: Asymptomatic infection, seroconversion, and chronicity rates. PLOS Neglected Tropical Diseases, 19(7), e0013254. https://doi.org/10.1371/journal.pntd.0013254
Vancouver
de Jesus Pereira B, Brasil MQA, Silva JJ, Cristal JR, Carvalho IP, Miranda MCP, et al. Chikungunya in a pediatric cohort: Asymptomatic infection, seroconversion, and chronicity rates. PLOS Neglected Tropical Diseases. 2025;19(7):e0013254. doi:10.1371/journal.pntd.0013254
BibTeX
@article{deJesusPereira2025,
author = {de Jesus Pereira, Blenda and Brasil, Michelle Queiroz Aguiar and Silva, Jessica de Jesus and Cristal, Juqueline Rocha and Carvalho, Isabele de Pádua and Miranda, Maria Carolina Prado and Paixão, Daniela and Khouri, Ricardo and Cerqueira-Silva, Thiago and Boulos, Fernanda Castro and Barral-Netto, Manoel and Kalas, Esper Georges and Barral, Aldina and Bandeira, Antônio and Boaventura, Viviane Sampaio},
title = {Chikungunya in a pediatric cohort: Asymptomatic infection, seroconversion, and chronicity rates},
journal = {PLOS Neglected Tropical Diseases},
year = {2025},
volume = {19},
number = {7},
pages = {e0013254},
doi = {10.1371/journal.pntd.0013254}
}
EUVIMED